Abstract
Trifluoperazine (TFP) has potential anticancer activity that was demonstrated in different types of cancer cells. However, little is known about its effects in the T-cell ALK+ anaplastic large cell lymphoma (ALCL). In this study, we investigated the effects of TFP in this aggressive type of cancer. The cytotoxicities of TFP on DEL and SUP-M2 cells were measured by trypan blue staining. The effects of TFP on cell cycle and apoptosis in DEL and SUP-M2 cells were determined by flow cytometry. The underlying anticancer mechanism of TFP was investigated by real-time PCR, Western Blotting, and nucleophosmin-ALK (NPM-ALK) tyrosine kinase assay in DEL cells. Our results show that TFP did not significantly affect cell viability of human normal lymphocytes, whereas it reduced the cell viability of the ALK+ T-cell lymphoma cells, DEL and SUP-M2, in concentration- and time-dependent manners. TFP also induced cell cycle arrest at G0/G1 phase, and caused cell apoptosis in these cells. These effects could be explained by the involvement of NPM-ALK and its downstream cell survival regulatory proteins. Our results demonstrate for the first time that TFP is capable of inducing degradation and inhibition of kinase activity of NPM-ALK, as well as ...Continue Reading
References
Apr 1, 1986·British Journal of Cancer·R GanapathiR Valenzuela
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·W N HaitE C Cadman
Feb 26, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L BrugièresO Hartmann
Dec 21, 2000·The Journal of Biological Chemistry·S Y ShinY H Lee
Nov 13, 2001·Oncogene·C GreenlandM Allouche
Jan 19, 2002·IUBMB Life·A Gross
Jan 24, 2002·Journal of Hepatology·Ziqiu WangBrian I Carr
Jan 31, 2002·World Journal of Gastroenterology : WJG·Hong-Yu XuLi-Jun Shi
Feb 19, 2002·Oncogene·Alberto ZamoGiorgio Inghirami
Apr 15, 2003·Experimental Hematology·Holger RuchatzCarlo Gambacorti-Passerini
Dec 10, 2003·Cancer Chemotherapy and Pharmacology·Zhivko ZhelevYoshinobu Baba
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph H LaverSharon B Murphy
Mar 15, 2006·Oncogene·T MochizukiT Kamata
May 19, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Soon Young ShinYoung Han Lee
May 24, 2007·Blood·Hesham M Amin, Raymond Lai
Jul 14, 2007·Mutation Research·Sudeshna GangopadhyayAnindita Chakraborty
Aug 11, 2007·Blood·Philipp B StaberGerald Hoefler
May 9, 2009·Blood·Ping ShiHesham M Amin
Sep 1, 2009·Molecular Medicine Reports·Qing Y ChenJian Y Zhou
Dec 15, 2012·Molecular Cancer Research : MCR·Monica CecconCarlo Gambacorti-Passerini
Jul 6, 2013·Oncology Reports·Jinyan ZhaoJun Peng
Feb 4, 2014·Leukemia Research·Farid Saei HamedaniSerhan Alkan
Nov 26, 2014·Molecular Cancer Research : MCR·M CecconC Gambacorti-Passerini
Feb 17, 2015·Oncogene·D ZhaoJ Slingerland
Feb 20, 2015·Proteins·Michael D FeldkampMadeline A Shea
Apr 18, 2015·BMC Cancer·Laure HumbertJean-Jacques Lebrun
Jan 8, 2017·Molecular Cancer Therapeutics·Seokmin KangSang Soo Kang